BMI View: The risks of investing in C?te d''Ivoire''s pharmaceutical and healthcare industry arenumerous. Politically, the country is in a fragile state, with concerns over security commonplace.Economically, C?te d''Ivoire posts a better performance, but there are many challenges to doing business inthe country, not least the presence of substandard drugs, lack of trained healthcare personnel, weak IPframework and supply chain concerns (such as a lack of suitable storage facilities in rural areas). Domesticdrug production - essential to reduce the government''s expensive import bill - is limited; only a fewmanufacturing facilities exist, mainly for the production of e...
No comments:
Post a Comment